fredrocko BP (NYSE:BP) expects to book impairment charges of $1B-$2B for Q2, and warned of weak oil trading earnings amid “significantly lower” refining margins, sending its shares falling 3.8% in premarket trade on Tuesday. The after-tax asset impairments and one-off contract provisions include charges relating to the ongoing review ofContinue Reading
extravagantni Soft U.K. economic growth is a factor in why many global investors have set aside British stocks, but discounted prices may steer investors into taking another look at the market as the country settles into a new government, according to Morgan Stanley. The Labour Party last week won controlContinue Reading
Iryna Drozd Adicet Bio (NASDAQ:ACET) stock jumped 10% Monday morning after the company said it had received FDA fast track designation for its CAR-T cell therapy candidate ADI-270 for the treatment of metastatic/advanced clear cell renal cell carcinoma, a type of kidney cancer. The designation was granted for the treatmentContinue Reading
designer491 Pulse Biosciences (NASDAQ:PLSE) stock rallied 22% in morning trading Monday after the medtech company said it had received FDA breakthrough device designation for its CellFX nanosecond pulse field ablation cardiac surgery system for the treatment of atrial fibrillation, or AFib. Pulse said it plans to pursue a premarket approvalContinue Reading
Comstock Images/Stockbyte via Getty Images Ally Financial (NYSE:ALLY) stock perked up 2.3% in Monday morning trading after J.P. Morgan upgraded the auto lender to Neutral from Underweight as analyst Richard Shane thinks its credit, net interest margin and multiple trajectory “have been overly conservative.” “As the impact of less profitableContinue Reading
Justin Sullivan/Getty Images News Charles Schwab (NYSE:SCHW) stock advanced 1.5% in Monday morning trading after Keefe, Bruyette & Woods upgraded the online brokerage to Outperform from Market Perform, owing to potentially robust earnings growth in the 2026-2030 period. “With greater confidence in a path forward from here, and with theContinue Reading
Ideaya Biosciences (NASDAQ:IDYA) shares jumped as much as 23% premarket on Monday after the oncology company reported positive interim data from an expansion dose cohort of a mid-stage trial of IDE397. IDE397 is a potential first-in-class MAT2A (methionine adenosyltransferase 2 alpha) inhibitor, that is being advanced as a monotherapy agentContinue Reading
hapabapa ServiceNow’s (NYSE:NOW) stock fell about 3% premarket on Monday after Guggenheim downgraded the shares to Sell from Neutral noting that the second quarter of 2024 is fine, but future risks don’t match valuation. The firm introduced a price target of $640 on the shares of the Santa Clara, Calif.-basedContinue Reading
Luis Alvarez Stock futures were mixed in the premarket hours of Monday as investors looked forward to key inflation data and the start of earnings season, which could impact the market rally, with several big companies across the financial, consumer, and technology sectors set to report quarterly results. Here areContinue Reading
David Becker/Getty Images News Nvidia’s (NASDAQ:NVDA) stock has rocketed 154% this year, its performance powered largely by a seemingly insatiable demand for its GPU chips amid the proliferation of AI technology. But Nvidia isn’t necessarily the only way to cash in on the chip feeding frenzy. Which brings us toContinue Reading
